| View |
|
DRP-13080
|
Ascorbic Acid + Zinc
|
VitaCinc Forte
|
500 mg (equivalent to 562.43 mg Sodium Ascorbate)/40
mg (equivalent to 109.80 mg Zinc Sulfate
|
Capsule
|
-
|
Phil. United Pharma Corporation
|
United States of America
|
Initial (OTC)
|
28 November 2022
|
28 November 2027
|
| View |
|
DRP-13045
|
Cefoxitin (As Sodium)
|
Cefoxsaph
|
1 g
|
Powder For Injection
|
-
|
Kilitch Drugs (India) Ltd.
|
India
|
Initial
|
22 November 2022
|
22 November 2027
|
| View |
|
DRP-13058
|
Clotrimazole
|
Accemazole
|
10mg/g (1% W/W)
|
Topical Cream
|
-
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
Initial (OTC)
|
23 November 2022
|
23 November 2027
|
| View |
|
DR-XY48505
|
Ascorbic Acid + Zinc+ Cholecalciferol (Vitamin D3)
|
Corcee Plus
|
500 mg (equivalent to 562.43 mg Sodium Ascorbate)/10 mg (equivalent to 70 mg Zinc Gluconate)/1,000 IU
|
Capsule
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial (OTC)
|
28 November 2022
|
28 November 2027
|
| View |
|
DRP-13047
|
Olopatadine (as hydrochloride
|
Optihist-Pat
|
1mg/ml (0.1% w/v)
|
Ophthalmic Solution (Eye Drops)
|
Antihistamine
|
Makcur Laboratories Limited
|
India
|
Initial (Re-application) (Reconstruction)
|
22 March 2024
|
22 November 2027
|
| View |
|
DRP-13056
|
Losartan Potassium
|
Losan 50
|
50mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Kopran Limited
|
India
|
Initial
|
23 November 2022
|
23 November 2027
|
| View |
|
DRP-13057
|
Mupirocin
|
Mupors
|
20mg/g (2% w/w)
|
Topical Ointment
|
-
|
Kwality Pharmaceutical Ltd.
|
India
|
Initial (OTC)
|
23 November 2022
|
23 November 2027
|
| View |
|
DRP-13046
|
Salbutamol (as Sulfate)
|
Inhalin-Neb
|
2.5 mg/2.5 mL
|
Solution for Inhalation
|
-
|
Eurolife Healthcare Pvt. Ltd.
|
India
|
Initial
|
25 November 2022
|
25 November 2027
|
| View |
|
DRP-13066
|
Ascorbic Acid + Zinc+ Colecalciferol (Vitamin D3)
|
BRTJ Formula Finest Choice Boosted
|
1 g/10 mg (equivalent to 40 mg Zinc Sulphate)/1000 IU
|
Film Coated Tablet
|
-
|
Vecta Biotech
|
India
|
Initial (OTC)
|
24 November 2022
|
24 November 2027
|
| View |
|
DRP-13070
|
Levetiracetam
|
None
|
100 mg/mL
|
Oral Solution (Grape Flavor)
|
-
|
Lifesquare Laboratories, Inc.
|
Philippines
|
Initial (Reapplication)
|
25 November 2022
|
25 November 2027
|
| View |
|
DRP-13083
|
Paracetamol
|
Fioramol
|
10mg/mL (1g/100mL)
|
Solution for Injection for I.V.
Infusion
|
-
|
PT. Bernofarm
|
Indonesia
|
Initial (Re-application)
|
25 November 2022
|
25 November 2027
|
| View |
|
DR-XY48499 (FOR EXPORT ONLY)
|
Brompheniramine Maleate + Phenylephrine
|
Dimetapp
|
2mg/5mg per 5 mL
|
Elixir
|
-
|
Interphil Laboratories, Inc.
|
Philippines
|
Initial (OTC)
|
25 November 2022
|
25 November 2027
|
| View |
|
DR-XY48501 (FOR EXPORT ONLY)
|
Brompheniramine Maleate + Phenylephrine
Hydrochloride + Dextromethorphan Hydrobromide
|
Dimetapp DM Cold and Cough Elixir (Colour Free)
|
2mg/5mg/10mg per 5mL
|
Elixir
|
-
|
Interphil Laboratories, Inc.
|
Philippines
|
Initial (OTC)
|
25 November 2022
|
25 November 2027
|
| View |
|
DR-XY48502 (FOR EXPORT ONLY)
|
Brompheniramine Maleate + Phenylephrine
Hydrochloride + Dextromethorphan Hydrobromide
|
Dimetapp DM Cold and Cough Elixir
|
2 mg/5 mg/10 mg per 5 mL
|
Elixir
|
-
|
Interphil Laboratories, Inc.
|
Philippines
|
Initial (OTC)
|
25 November 2022
|
25 November 2027
|
| View |
|
DRP-13054
|
Butamirate Citrate
|
Saphmirate
|
7.5mg/5mL
|
Syrup
|
-
|
Enicar Pharmaceuticals Pvt. Ltd.
|
India
|
Initial (OTC)
|
23 November 2022
|
23 November 2027
|
| View |
|
DR-XY48489 (For Export Only)
|
Dextromethorphan Hydrobromide
|
Robitussin DX
|
30mg/10mL
|
Syrup
|
-
|
Interphil Laboratories, Inc.
|
Philippines
|
Initial [OTC]
|
23 November 2022
|
23 November 2027
|
| View |
|
DRP-13081
|
Multivitamins + Zinc
|
Vitz-Ace
|
Formulation:
Each capsule contains:
Ascorbic Acid (Vitamin C)-500 mg
dl-alpha Tocopheryl Acetate (Vitamin E)-200mg (100IU)
Retinol Acetate (Vitamin A)-10mg (5000IU)
Zinc (equivalent to 68.625 mg Zinc Sulfate Monohydrate)-25mg
|
Capsule
|
-
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial (OTC)
|
28 November 2022
|
28 November 2027
|
| View |
BR-1433_PI_01.pdf
|
BR-1433
|
Insulin Degludec + Insulin Aspart
|
Ryzodeg Flextouch
|
100 Units/mL (70% Insulin Degludec/30% Insulin
Aspart)
|
Solution for Injection (SC)
|
-
|
Novo Nordisk Production SAS
|
France
|
Initial (Re-application)
|
25 November 2022
|
25 November 2027
|
| View |
|
DRP-13049
|
Citicoline (As Sodium)
|
Ancoline-500
|
500 mg
|
Film-Coated Tablet
|
-
|
Hiral Labs Limited
|
India
|
Initial
|
22 November 2022
|
22 November 2027
|
| View |
|
DR-XY48507
|
Atracurium Besilate
|
Kabitran
|
10mg/mL
|
Solution for Injection (IV)
|
-
|
PT. Ethica Industri Farmasi (PT. Ethica)
|
Indonesia
|
Initial
|
28 November 2022
|
28 November 2027
|